.Speaker Group: International Womens Day

Seonhi Ro

A professional leader with excellent technical and business knowledge and experience. Especially connectivity between new technologies, data analytics and business application in automotive industry. Driving results and optimistic with considering risk management. Professional team work especially between international and cross functional teams with complex topics. Pragmatic and data driven decision maker. Experience in industry 4.0… Read more »

Jen Yip

At Novartis, Jen’s mission is to find novel approaches to leveraging data and technology to design better clinical trials, accelerate patient recruitment, drive patient engagement, and re-imagine clinical trial data collection and management. Before joining Novartis, Jen held global clinical and commercial digital innovation roles at other big pharma and led global product marketing in… Read more »

Amie Moreno

Amie Moreno Precision Digital Health

Amie brings to PDH over 15 years of experience in the Life Sciences and Biotech industry.  Amie successfully forges and strengthens strategic partnerships with pharmaceutical, biotech, and clinical research organizations (CRO), producing long-lasting value for these partnerships. Amie acts as the partner’s advocate and voice in identifying and implementing business and technological solutions for the… Read more »

Samantha Pearman-Kanza P.h.D.

Samantha Kanza University of Southampton

Dr Samantha Pearman-Kanza is a Senior Enterprise Fellow at the University of Southampton. She is a Pathfinder Lead on Process Recording for the Physical Sciences Data Infrastructure (PSDI) Initative. She coordinates the AI 4 Scientific Discovery Network (AI4SD – www.ai4science.network) run out of Southampton, and the Future Blood Testing Network (www.futurebloodtesting.org) run out of Reading…. Read more »

Tuyen Nguyen

Tuyen Nguyen is a Principal Scientist at Alnylam Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. She is leading the target discovery and validation, and overseas the in vitro high throughput screening pipeline.   She is also leading the CNS and Ocular assay… Read more »